Positions

Overview

  • Dr. Stephen Gray completed his general surgery training and abdominal transplant fellowship at the University of Alabama at Birmingham in 2012. Prior to training at University of Alabama at Birmingham, He obtained a BS from Oakwood University in Huntsville, AL and completed his M.D. at the University of Michigan in Ann Arbor, MI. Dr. Gray has been a faculty member in the Department of Surgery since 2012.

    Dr. Gray’s clinical interest is abdominal organ transplant. He specializes in liver transplantation and hepatobiliary surgery. He does both adult and pediatric liver transplantation and pediatric renal transplantation. Dr. Gray is involved in evaluating, managing, and treating patients with end stage liver disease from a transplant surgery standpoint, including management of complications of cirrhosis, management of immunosuppression, and optimization of medical comorbidities.

    Dr. Gray’s research interest primarily pertain to liver transplant candidate evaluation, management, and outcomes for adults, ensuring that culturally and ethnically appropriate assessment strategies are used to eliminate age and racial health disparities. Dr. Gray has a specific interest in the assessment and selection of appropriate older adults for liver transplantation. Additionally, he has been appointed as scholar in the UAB Comprehensive Center for Healthy Aging, which has allowed me to develop mentoring relationships with geriatric clinician-scientists. He previously earned a MSPH in Clinical Research from University of Alabama at Birmingham School of Public Health. He also has an interest in health services research, specifically identifying modifiable predictors of transplant outcomes.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist CandidatesTransplantation.  103:1425-1432. 2019
    2018 Accessibility and content of abdominal transplant fellowship program websites in the United StatesJournal of Surgical Research.  232:271-274. 2018
    2018 The role of transesophageal echocardiography in the management of renal cell carcinoma with venous tumor thrombusEchocardiography.  35:2047-2055. 2018
    2018 Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidatesAmerican Journal of Transplantation.  18:1947-1953. 2018
    2018 Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation systemAmerican Journal of Transplantation.  18:1690-1698. 2018
    2018 Bleeding at Roux-en-Y jejunojejunal anastomosis after orthotopic liver transplantationVideogie.  3:179-180. 2018
    2017 Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement?Hepatology Communications.  1:338-346. 2017
    2017 A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized TherapyJVIR: Journal of Vascular and Interventional Radiology.  28:231-237.e2. 2017
    2017 Outcomes of Patients Who Undergo Cardiac Surgical Procedures After Liver TransplantationAnnals of Thoracic Surgery.  103:541-545. 2017
    2016 Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation OutcomesJournal of The American College of Surgeons.  223:611-620.e4. 2016
    2016 Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?Journal of Oncology.  2016. 2016
    2015 Resolution of post-liver transplant anastomotic biliary stricture with successful placement of a self-expanding metallic stent in a childEndoscopy.  47:E444-E445. 2015
    2015 Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cmHPB.  17:140-149. 2015
    2015 The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costsAmerican Journal of Transplantation.  15:541-546. 2015
    2014 Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteriaTransplantation.  97:1043-1048. 2014
    2014 Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolizationHPB.  16:327-335. 2014
    2014 Risk factors associated with reoperation for bleeding following liver transplantationHPB Surgery.  2014. 2014
    2013 Do trained specialists solicit familial authorization at equal frequency, regardless of deceased donor characteristics?Journal of Transplant Coordination.  23:290-296. 2013
    2013 What liver transplant outcomes can be expected in the uninsured who become insured via the affordable care act?American Journal of Transplantation.  13:1533-1540. 2013
    2012 Is decedent race an independent predictor of organ donor consent or merely a surrogate marker of socioeconomic status?Transplantation.  94:873-878. 2012
    2012 Outcomes for incisional hernia repair in patients undergoing concomitant surgical proceduresAmerican Surgeon.  78:243-249. 2012
    2012 Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseasesHPB.  14:625-634. 2012
    2011 Descriptive operative reports: Teaching, learning, and milestones to safe surgeryCurrent Surgery.  68:452-458. 2011
    2011 Outcomes of emergent incisional hernia repairAmerican Surgeon.  77:971-976. 2011
    2011 Predictors of mesh explantation after incisional hernia repairAmerican Journal of Surgery.  202:28-33. 2011
    2011 Effect of mesh type and position on subsequent abdominal operations after incisional hernia repairJournal of The American College of Surgeons.  212:496-502. 2011
    2011 Patient satisfaction, chronic pain, and quality of life after elective incisional hernia repair: Effects of recurrence and repair techniqueHernia.  15:123-129. 2011
    2011 Hospital-level variability in incisional hernia repair technique affects patient outcomesSurgery.  149:185-191. 2011
    2010 Long-Term Follow-Up of Technical Outcomes for Incisional Hernia RepairJournal of The American College of Surgeons.  210:648-655. 2010
    2008 Variation in mesh placement for ventral hernia repair: an opportunity for process improvement?American Journal of Surgery.  196:201-206. 2008
    2008 DiscussionAmerican Surgeon.  74:605-606. 2008
    2008 Does cholecystectomy prior to the diagnosis of pancreatic cancer affect outcome?American Surgeon.  74:602-605. 2008
    2008 Risk of complications from enterotomy or unplanned bowel resection during elective hernia repairArchives of Surgery -New York-.  143:582-586. 2008
    2008 Association of Timely Administration of Prophylactic Antibiotics for Major Surgical Procedures and Surgical Site InfectionJournal of The American College of Surgeons.  206:814-819. 2008
    2008 Umbilical herniorrhapy in cirrhosis: Improved outcomes with elective repairJournal of Gastrointestinal Surgery.  12:675-681. 2008
    2008 Surgical Progress in Inguinal and Ventral Incisional Hernia RepairSurgical Clinics of North America.  88:17-26. 2008
    2006 Timely Administration of Prophylactic Antibiotics for Major Surgical ProceduresJournal of The American College of Surgeons.  203:803-811. 2006

    Chapter

    Year Title Altmetric
    2014 Surgical management of gastroesophageal varices.  205-232. 2014

    Research Overview

  • liver transplantation, hepatobiliary surgery, outcomes research, health disparities research
  • Investigator On

  • ACES - ACE Inhibitors Combined with Exercise for Hypertensive Seniors  awarded by National Institute on Aging/NIH/DHHS 2017 - 2022
  • Private Grant  awarded by ORGANOX LIMITED 2016 - 2021
  • Precision High Intensity Training through Epigenetics (PHITE)  awarded by Wright State University 2016 - 2020
  • Resveratrol and Exercise to Treat Functional Limitations in Late Life  awarded by National Institute on Aging/NIH/DHHS 2018 - 2020
  • UAB Center for Clinical and Translational Science (CCTS) (3 Linked Awards UL1, KL2, TL1)  awarded by National Center for Advancing Translational Sciences/NIH/DHHS 2015 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2015 - 2019
  • UAB NRG Oncology Member Institution Purchased Service Agreement  awarded by NRG ONCOLOGY FOUNDATION 2014 - 2019
  • Private Grant  awarded by MERIT MEDICAL (*) 2012 - 2019
  • Deep South Resource Center for Minority Aging Research (RCMAR)  awarded by National Institute on Aging/NIH/DHHS 2013 - 2018
  • UAB 1356: A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)  awarded by University of California, Los Angeles 2015 - 2018
  • Private Grant  awarded by BOSTON SCIENTIFIC CORPORATION 2016 - 2017
  • Deep South Resource Center for Minority Aging Research - Diversity Supplement - Stephen Gray  awarded by NIH - National Institutes of Health/DHHS 2014 - 2016
  • Indefinite-Delivery-Indefinite-Quantity  awarded by Health Resources and Services Administration/DHHS 2013 - 2015
  • UAB 1356 - A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotropic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)  awarded by University of California, Los Angeles 2014 - 2015
  • Deep South Resource Center for Minority Aging Research  awarded by National Institute on Aging/NIH/DHHS 2012 - 2014
  • Private Grant  awarded by VITAL THERAPIES, INC 2012 - 2014
  • Education And Training

  • UAB Hospital, Internship 2004
  • UAB Hospital, Residency 2010
  • UAB Hospital, Residency 2005
  • UAB Hospital, Postdoctoral Fellowship 2012
  • Health Services and Outcomes Research Training, Postdoctoral Fellowship 2007
  • Full Name

  • Stephen Gray